Eicosatetraenoic Acid (ETA) – Effects & Sources

What is Eicosatetraenoic Acid?

Eicosatetraenoic acid (abbreviated ETA) is a long-chain, polyunsaturated fatty acid belonging to the omega-3 family. It contains 20 carbon atoms and four double bonds, giving it the scientific designation 20:4(n-3), or more specifically all-cis-5,8,11,14-eicosatetraenoic acid depending on the isomer. ETA is found naturally in relatively few food sources, with the New Zealand green-lipped mussel (Perna canaliculus) being the most well-known dietary source. It has attracted scientific interest primarily due to its potent anti-inflammatory mechanisms.

Biological Function and Mechanism of Action

ETA exerts its biological effects through several interconnected pathways in the inflammatory cascade:

• Inhibition of Delta-5-Desaturase: ETA inhibits the enzyme Delta-5-desaturase, which normally converts dihomo-gamma-linolenic acid (DGLA) into arachidonic acid (AA). By blocking this step, ETA reduces the availability of arachidonic acid, the main precursor of pro-inflammatory eicosanoids.
• Competition with arachidonic acid: ETA competes with arachidonic acid for access to the enzymes cyclooxygenase (COX) and lipoxygenase (LOX), thereby reducing the production of pro-inflammatory prostaglandins and leukotrienes.
• Elevation of DGLA metabolites: By inhibiting Delta-5-desaturase, DGLA levels rise, promoting the formation of Series 1 prostaglandins, which have anti-inflammatory effects.

Dietary Sources

ETA is found in only a limited number of natural food sources in meaningful quantities:

• New Zealand green-lipped mussel (Perna canaliculus): This shellfish species contains a unique fatty acid profile that includes ETA and forms the basis of many commercially available dietary supplements.
• Other marine organisms may also contain trace amounts of ETA.

Unlike the better-known omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), ETA is not typically found in common fish oils or plant-based oils, making it a relatively rare dietary fatty acid.

Medical Significance and Areas of Application

The anti-inflammatory properties of ETA make it of potential therapeutic relevance in conditions where chronic inflammation plays a central role:

• Arthritis and joint disorders: Preclinical and clinical studies suggest that ETA-containing green-lipped mussel extracts may help reduce joint inflammation and associated pain.
• Chronic inflammatory conditions: ETA is being explored as a supportive agent in conditions such as rheumatoid arthritis and inflammatory bowel disease.
• Pain management: By reducing the production of pro-inflammatory mediators, ETA may contribute to pain relief in inflammatory conditions.

Dosage and Supplementation

ETA is primarily consumed through dietary supplements based on green-lipped mussel extract. No official recommended daily intake for ETA has been established. Clinical studies have typically used green-lipped mussel extracts at doses of 300 to 1,200 mg per day. Since ETA represents only a fraction of the total fatty acid content in such extracts, the exact amount of ETA per supplement varies and should be checked on individual product labels.

Safety and Interactions

ETA is generally considered safe when consumed through food sources or supplements at typical doses. However, the following considerations apply:

• Shellfish allergy: Individuals with a known allergy to shellfish should avoid mussel-based ETA supplements.
• Interactions with anticoagulants: Like other omega-3 fatty acids, ETA may prolong bleeding time and potentially interact with blood-thinning medications such as warfarin.
• Pregnancy and breastfeeding: Insufficient data exist regarding the safety of ETA supplements during pregnancy and lactation; medical consultation is advised.

Scientific Evidence

Research specifically focused on ETA as an isolated compound is still emerging. Much of the existing evidence comes from in vitro studies and animal models. Clinical trials in humans targeting ETA specifically are limited. However, the broader body of evidence supports the anti-inflammatory and analgesic effects of green-lipped mussel extracts, which contain ETA alongside other bioactive compounds. Several clinical trials and meta-analyses have demonstrated benefits for inflammatory joint conditions. Determining the precise contribution of ETA relative to other fatty acids within the extract remains an active area of research.

References

1. Mickleborough, T.D. (2013): Omega-3 polyunsaturated fatty acids in physical performance optimization. International Journal of Sport Nutrition and Exercise Metabolism, 23(1), 83–96.
2. Treschow, A.P. et al. (2007): Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 147(4), 645–656.
3. Halpern, G.M. (2000): Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Allergie et Immunologie, 32(7), 272–278.